<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/421B4793-37B1-4BD6-AAD9-8B6C240ED8C9"><gtr:id>421B4793-37B1-4BD6-AAD9-8B6C240ED8C9</gtr:id><gtr:name>Duke University</gtr:name><gtr:address><gtr:line1>Edmund T Pratt</gtr:line1><gtr:postCode>27708-0300</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/EDF9EB53-008B-4F75-A492-AC1ADCFE76F0"><gtr:id>EDF9EB53-008B-4F75-A492-AC1ADCFE76F0</gtr:id><gtr:name>Royal Free Hampstead NHS Trust</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AA7CF37A-1A3C-4DC6-8488-4445B285ACA2"><gtr:id>AA7CF37A-1A3C-4DC6-8488-4445B285ACA2</gtr:id><gtr:name>Genentech</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/421B4793-37B1-4BD6-AAD9-8B6C240ED8C9"><gtr:id>421B4793-37B1-4BD6-AAD9-8B6C240ED8C9</gtr:id><gtr:name>Duke University</gtr:name><gtr:address><gtr:line1>Edmund T Pratt</gtr:line1><gtr:postCode>27708-0300</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EDF9EB53-008B-4F75-A492-AC1ADCFE76F0"><gtr:id>EDF9EB53-008B-4F75-A492-AC1ADCFE76F0</gtr:id><gtr:name>Royal Free Hampstead NHS Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AA7CF37A-1A3C-4DC6-8488-4445B285ACA2"><gtr:id>AA7CF37A-1A3C-4DC6-8488-4445B285ACA2</gtr:id><gtr:name>Genentech</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0DD3CC53-8B1D-4819-A4E8-C6F5FB7C9D67"><gtr:id>0DD3CC53-8B1D-4819-A4E8-C6F5FB7C9D67</gtr:id><gtr:firstName>Jane</gtr:firstName><gtr:otherNames>Caroline</gtr:otherNames><gtr:surname>Goodall</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6A318955-454F-45C9-A511-C86B5325BCD9"><gtr:id>6A318955-454F-45C9-A511-C86B5325BCD9</gtr:id><gtr:firstName>Hill</gtr:firstName><gtr:surname>Gaston</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9555A3CA-F380-492C-9146-B05CEC0D86E4"><gtr:id>9555A3CA-F380-492C-9146-B05CEC0D86E4</gtr:id><gtr:firstName>Michael Paul</gtr:firstName><gtr:surname>Weekes</gtr:surname><gtr:orcidId>0000-0003-3196-5545</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FM020134%2F1"><gtr:id>AD63082A-778D-45D2-8DF5-35EF32091121</gtr:id><gtr:title>A dynamic insight into the interaction of Chlamydia trachomatis with host cells</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M020134/1</gtr:grantReference><gtr:abstractText>Infection by the bacteria Chlamydia trachomatis, or chlamydia, imparts a large burden on society, particularly amongst young adults. It contributes significantly to the prevalence of sexually transmitted diseases and is a key cause of infertility and preventable blindness. Unlike many other types of bacteria, chlamydia cannot replicate outside of a cell. It is obligated to enter a cell in order to reproduce. As a result, it has evolved the ability to manipulate the environment of the host cell to keep the cell alive for the appropriate length of time; because if the host cell dies too quickly, the chlamydia will also die. In order to develop strategies to tackle this major public health problem, we will need to have a better understanding of what happens to the host cell and to the chlamydia during the infection process. Thus we will use a powerful new technique, which will allow us to accurately determine what happens to host cell and chlamydia proteins, as well as how they interact with each other, over the course of the infectious life cycle. In addition, we want to identify whether the chlamydia prevents the body's immune system or defence mechanisms working properly We think that the chlamydia may influence the types of proteins on the surface of the cell, and change the way the immune system cells react to an infection, so that the bacteria can persist. In order to study this, we will compare the proteins on the cell surface before and after infection. Both these approaches will help us better understand how chlamydia successfully enters cells, replicates and manipulates its environment. This knowledge is critical if we are to devise strategies to prevent humans succumbing to the infection and most importantly, the irreversible damage to the body that results in blindness and infertility.</gtr:abstractText><gtr:technicalSummary>Chlamydia trachomatis (CT) infection imparts a large burden on the human population, particularly amongst young adults, contributing significantly to the prevalence of sexually transmitted diseases, infertility and preventable blindness. CT is an obligate intracellular bacterium that is exquisitely adapted to manipulate the environment of the host cell. In contrast to gene expression studies, there is no information on the global protein changes that occur during the infectious process. Thus, we will utilise a powerful multiplexed proteomic technique that allows the relative abundance of chlamydia and host proteins to be determined accurately over the course of the infectious life cycle in both human epithelial and dendritic cells. This approach will provide the first opportunity to interrogate the chlamydia and host protein responses in tandem and provide a dynamic insight into the chlamydia-host interaction. A quantitative proteomics approach provides the opportunity to interrogate the biology of CT which has not been readily amenable to genetic manipulation approaches. 
CT infection is also characterised by silent infection and inappropriate or inadequate cellular immunity to prevent reinfection. The plasma membrane provides a critical nexus with immune system cells and we hypothesize that changes in host cell plasma membrane proteins induced by CT infection may be critical in the modulation of immune responses. To address this, we will compare proteomic changes in the surface exposed membrane of human epithelial and dendritic cells infected CT. Both these approaches will identify pathways in the host cell response that that may be critical for either CT replication, induction of inflammatory responses and deviation of immune system responses. Most importantly, this study will inform potential approaches to prevent successful Chlamydia infection and its inflammatory sequelae in humans.</gtr:technicalSummary><gtr:potentialImpactText>Who will benefit from this research and how?

The immediate academic beneficiaries from this research would be the chlamydia research community. We will be providing important datasets of both the chlamydial proteome from disease relevant chlamydia strains and in addition a careful description of the host cell proteome response to these pathogens. However, if these results improve our understanding of the mechanisms underlying Chlamydia pathogenesis, it is certainly not too far-fetched to imagine that, the human population could directly benefit from improved diagnostics and treatment options and preventative measures that may occur as a result of these findings. The identification of novel chlamydia molecules that modulate the host cells will progress our understanding of immune response pathways and eventually inform interventions to treat or prevent inflammation and scarring associated with infection, thus impacting on human health.

Societal impact
Chlamydia infection is currently a large burden to human health. It is the leading cause of preventable blindness and one of the major causes of infertility. Thus, any progress made within the context of this project, that improves therapeutic and preventative strategies for chlamydia infection and treatment, no matter how small, would have significant impact. Although a significant reduction in incidence of trachoma and sexually transmitted chlamydia infection could be achieved by improvement in living conditions and a change in sexual behaviour. This must be accompanied by research that increases the understanding of the underlying mechanisms of chlamydia infection and the pathogenic process to enable the development of complementary strategies to combat the disease.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>358210</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Radboud University Nijmegen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Molecular Biology</gtr:department><gtr:description>Role of STING in inflammasome activation</gtr:description><gtr:id>66639854-BE85-4247-B77A-D80125D44F90</gtr:id><gtr:impact>Manuscript in preparation</gtr:impact><gtr:partnerContribution>Provision of bine marrow tissue from Wildtype and STING KO mice</gtr:partnerContribution><gtr:piContribution>The aim of this collaborationwas to determine the role of STING in the activation of the inflammasome.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Duke University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Raphael Valdvia</gtr:description><gtr:id>0BEBA17D-F7B1-4BFE-B84A-6710329AD375</gtr:id><gtr:impact>We are in the process of preparing a publication</gtr:impact><gtr:partnerContribution>Provision of mutant Chlamydia strains</gtr:partnerContribution><gtr:piContribution>Analysis of a Chlamydia mutant bacteria</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Free Hampstead NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Provision of CGD patients</gtr:description><gtr:id>A14DCB07-60A2-48CD-8873-C2EC85DA5F3D</gtr:id><gtr:impact>Publication submitted to the microbes and infection.</gtr:impact><gtr:partnerContribution>Provision of CGD patients</gtr:partnerContribution><gtr:piContribution>Analysis of the differentiated monocytes obtained from CGD patients</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genentech</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Vishva Dixit</gtr:description><gtr:id>BC114B2E-D38B-4918-A7B9-4F7F18E72BC3</gtr:id><gtr:impact>Publication in progress</gtr:impact><gtr:partnerContribution>Provision of tissue for analysis of the role of inflammasome components in IL-1beta response of dendriric cells to Chlamydia.</gtr:partnerContribution><gtr:piContribution>Analysis of the inflammasome and Gasdermin KO tissue in the context of chlamydia infection</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Role of reactive oxygen species in inflammation</gtr:description><gtr:id>EE5B36B6-9DAE-4198-AD34-0ADD1CAFFDE0</gtr:id><gtr:impact>Submitted publication to microbes and Infection</gtr:impact><gtr:partnerContribution>Provision of transgenic mice</gtr:partnerContribution><gtr:piContribution>Used cybb-/- mice to analyse the role of ROS in the induction of IL-1beta induced by chlamydia infection</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Year 11 Introduction to Science and IT , UTC Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E96E4877-AB2A-4A25-96F9-5FE8DEC9D8B0</gtr:id><gtr:impact>In order to prepare our year 11 students for the future, I took part in a career event in Science and IT career opportunities in scientific research at the UTC, Cambridge. I provided an interactive workshop on aspects of scientific research and gave the students an opportunity to ask questions about career choices, career pathways, working conditions, job roles and responsibilities.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Attendance at 7th Biennial Meeting of the Chlamydia Basic Research Society April 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A24AECCA-74C4-45BD-9C5C-8494C7916BEC</gtr:id><gtr:impact>I presented the work to leaders in the field of chlamydia immunology and I was given very useful feedback and have formed some very useful collaborations. I will also sharing my data with a number of investigators to increase the impact of my work. There was a lot of interest in the technique I was using and I was able to discuss this with participants during my poster session.
Collaborations formed with Raphael Valdivia at Duke university. North Carolina.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ER stress, autophagy and inflammation conference in Bruge 2017.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BD43B8D6-91A3-4F2C-B183-D6C9613C2AA6</gtr:id><gtr:impact>Attended a meeting on the role of ER stress in inflammation. This meeting was critical to allow the networking and dissemination of information</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Society of Immunology Annual meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0128BFC9-CFCD-4DE8-9A65-EBDE485C4822</gtr:id><gtr:impact>Presentation of a talk on the role of ER stress and pathogen associated molecules that result in the induction of pro-inflammatory cytokines to the attendees of the shared annual meeting of British Society for Immunology and the Dutch Society for Immunology, This talk was attended by scientists with an interest in the role of cytokines and macrophages in inflammation.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at Oxford Glycobiology Institute</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3FFBBB20-124C-43D5-9C59-BE83BA884560</gtr:id><gtr:impact>Lecture of my research This has resulted in a collaboration with Prof Joanna Miller, Glycobiology unit, University of Oxford.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster presentation at Cambridge Immunology forum 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>848EEC68-ED1A-4F9B-BE2E-C0145E656249</gtr:id><gtr:impact>Poster presentation:STING regulates non-canonical inflammasome activation in response to Chlamydia trachomatis infection.
We were able to show our data and discusss with other leaders in the field of infection and inflammation. 
As a result of this meeting we collaborated with Prof Vishva Dixit at Genentech</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MR/M020134/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>